The Human Insulin Market, which was valued at USD 24.88 billion in 2018, is expected to witness significant growth with a projected compound annual growth rate (CAGR) of 8.1%. It is estimated that by 2026, the market will surpass USD 46.59 billion. The growth of this market is primarily fueled by the increasing prevalence of diabetes and obesity on a global scale, which can be attributed to unhealthy lifestyles. In 2015, for example, more than 30 million Americans (9.4% of the population) were diagnosed with diabetes, with 23.1 million individuals having received a diagnosis and the remaining 7.2 million being undiagnosed.
https://www.reportsanddata.com..../report-detail/human
Like
Comment
Share
